Member Log-in

I forgot my password

Not a Member? Register

Expenditures on Vaccine-preventable Disease Surveillance: Analysis and Evaluation of Comprehensive Multi-year Plans (cMYPs) for Immunization

Despite the importance of vaccine-preventable disease (VPD) surveillance, little is known about the costs of monitoring disease. Researchers used Comprehensive Multi-Year Plans for Immunization (cMYPs) – developed by countries following guidelines from the World Health Organization and United Nations Children’s Fund – to estimate expenditures on VPD surveillance at the country level in 2015 US Dollars (USD) in 63 low- and middle-income countries. To evaluate the reliability of cMYP estimates, researchers also compared cMYP data with findings from previous research studies and assessed whether countries explicitly budgeted for major categories of surveillance activities in their plans for immunization. According to this analysis of cMYPs, countries spent an annual median of $406,108 on VPD surveillance ($0.04 per capita and $1.47 per infant), with reported expenditures ranging from $1,098 (Kiribati) to $21,644,770 (Nigeria). However, the majority of countries failed to explicitly mention several key categories of surveillance activities in their plans, especially laboratory-related surveillance activities. The results show a large amount of variation in surveillance expenditures (total, per capita, and per infant) between countries and provide insights to improve costing guidelines and practices.

Read the full paper.

You May Also Like

WHO Guide for Standardization of Economic Evaluations of Immunization Programs

WHO has recently published a new edition of the guidance to meet the increased need to carry out immunization economic evaluations for decision making using the latest methodologies. This updated guide brings together the recommendations and guidance from many recent guidelines, tools and other documents on specific aspects of immunization and on specific vaccines. The … Continued

Sabin’s Sustainable Immunization Financing (SIF) Program: A Decade of Sustainable Immunization Financing

Immunization is among the most impactful and cost-effective health investments a nation can make. However, with the introduction of new vaccines, the cost to vaccinate a child continues to rise. Many low- and middle-income countries that currently receive financial support for their immunization programs will no longer be eligible by 2020 due to their growing … Continued

The Costs of Delivering Vaccines in Low- and Middle-income Countries: Findings from a Systematic Review

Abstract Information on immunization delivery costs (IDCs) is essential for better planning and budgeting for the sustainability and performance of national programs. However, delivery cost evidence is fragmented and of variable quality, making it difficult for policymakers, planners, and other stakeholders to understand and use. This study aimed to consolidate and summarize the evidence on … Continued

Choose a Language